Robinson Unmanned R44 AIRTRUCK Demonstrates Offshore Cargo Capabilities at Acadiana Regional Airport in Louisiana

Last week, the Robinson Unmanned R44 AIRTRUCK, an unmanned, remotely piloted cargo helicopter, completed a series of ...

UK’s MHRA Accepts Biosplice’s Application for Lorecivivint (LOR) in Knee Osteoarthritis and Begins Assessment

In its acknowledgement notification, the MHRA confirmed that preliminary checks of the LOR dossier have been completed, that ...

Brixton Metals Reports Consistent Silver Grades Across All 85 Holes from Maiden Tailings Drill Program at the Langis Silver Project

85 sonic drill holes completed over the mapped tailings extent; all 85 holes returned silver-mineralized tailings material. Highest-grade result of 311.7 g/t silver over 1.53 m in LT-26-051, including ...

Nasus Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus", “Nasus Pharma” or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced that ...

Polar Power Reduces Pinnacle Bank Debt by $3 Million, from Approximately $4.7 Million to $1.667 Million; Expects Remaining Balance to Be Paid Down by End of September

Separately, since June 30, 2026, the Company has reduced the Pinnacle Bank balance by approximately $1.0 million, from approximately $2.7 million to approximately $1.7 million currently. Based on its ...

Fujifilm Launches “VF-GFXC2” Electronic Viewfinder for the “FUJIFILM GFX ETERNA 55”

Industry-leading 2048 x 1536-dot resolution and brightness of up to 1,000 nits Display design optimized for 4:3 open-gate ...

SPIRIT BLOCKCHAIN CAPITAL ANNOUNCES NAME CHANGE TO IMPAUER TECHNOLOGIES INC. AND NEW TRADING SYMBOLS

In connection with the Name Change, the Company’s common shares will trade on the Canadian Securities Exchange (the “CSE”) under the new name Impauer Technologies Inc. and new trading symbol “IMPR”.

Vor Completes Enrollment of Global Phase 3 UPSTREAM MG Trial and Expands Telitacicept Global Franchise into Ocular Myasthenia Gravis

Topline results from UPSTREAM MG’s 24-week primary endpoint remain on track for first half of 2027Global Phase 3 ocular myasthenia gravis (oMG) ...

Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company

Medicus Pharma Ltd. (Nasdaq: MDCX) is a precision-guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutic assets.

OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye ...

Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026

Two abstracts selected for oral presentations, highlighting investigational CAR-NK cell therapy’s clinical activity in idiopathic inflammatory ...

Newron Reports Subscription for EUR 5.5 Million of Shares by Investor Group as Part of Up to EUR 38 Million Total Financing to Advance Phase 3 Evenamide Program

Newron Pharmaceuticals S.p.A. (“Newron”, or the “Company”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central ...